CLL

April 14, 2016April 14, 2016

LLS Welcomes FDA Approval of Venclexta to Treat Certain Chronic Lymphocytic Leukemias

News

The Leukemia & Lymphoma Society (LLS) welcomed the recent approval of Venclexta (venetoclax) to treat people with a severe form of chronic lymphocytic leukemia (CLL). The drug, whose development and testing the LLS supported, ... Read more

March 21, 2016

Towards Targeted Therapy in CLL and Lymphoma

In this Patient Power Europe video filmed at the 2015 American Society of Clinical Oncology (ASCO), meet Dr. Jacqueline Barrientos, while she explains how recent progress in the treatment of chronic ... Read more

March 21, 2016May 13, 2016

Hodgkin’s Lymphoma and CLL Are Newest Patient Guidelines from the Cancer Network

News

The National Comprehensive Cancer Network has announced the publication of NCCN Guidelines for Patients with chronic lymphocytic leukemia (CLL) and Hodgkin’s lymphoma, and a new NCCN Quick Guide series, to help people better understand the disease and ... Read more

September 1, 2015September 1, 2015

Phase II Study of Investigational Medicine Venetoclax Meets Primary Endpoint With Positive Results

News

Genentech in partnership with AbbVie Pharmaceuticals and the Leukemia & Lymphoma Society (LLS), recently announced positive results from a Phase 1 clinical trial for venetoclax, an investigational therapy to treat patients with ... Read more